Catalyst Wire Dossier Catalyst Wire Dossier

SPIRIVA HANDIHALER

TIOTROPIUM BROMIDE · Boehringer Ingelheim Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for SPIRIVA HANDIHALER, covering 2006-09-20 to 2024-12-30. Get the full timeline:

Most recent: FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing